XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,116,000 | – | 419,469 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $8,970,000 | 0.44% |
| Alpine Global Management, LLC | 370,000 | $907,000 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 460,500 | $1,128,000 | 0.17% |
| IHT Wealth Management, LLC | 334,367 | $819,000 | 0.07% |
| Redmile Group, LLC | 1,358,825 | $3,329,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 58,025 | $142,000 | 0.04% |
| Granahan Investment Management | 465,049 | $1,139,000 | 0.02% |
| SEARLE & CO. | 20,000 | $49,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 402,300 | $986,000 | 0.02% |
| Gladstone Institutional Advisory LLC | 53,500 | $131 | 0.01% |